Yubo International Biotech Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.00797 million compared to USD 0.351471 million a year ago. Net loss was USD 0.491559 million compared to USD 0.370008 million a year ago.
For the six months, sales was USD 0.023183 million compared to USD 0.8138 million a year ago. Net loss was USD 1.07 million compared to USD 0.808683 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.